Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

FREDUN PHARMACEUTICALS LTD.

NSE : NABSE : 539730ISIN CODE : INE194R01017Industry : Pharmaceuticals & DrugsHouse : Private

BSE1294.9016.05 (+1.26 %)

PREV CLOSE ( ) 1278.85

OPEN PRICE ( ) 1304.45

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 8798

TODAY'S LOW / HIGH ( )1260.10 1325.00

52 WK LOW / HIGH ( ) 6351329

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 08-06 1987

Management Info

Daulat N Medhora - Chairman Fredun N Medhora - Managing Director

Registered Office

Address 11th Floor, Tower A,Urmi Estate 95, Ganpatrao Kadam Marg,Lower Parel (West),
Mumbai,
Maharashtra-400013

Phone 022-40318111

Email business@fredungroup.com

Website www.fredungroup.com

Registrars Details

Purva Shareregistry (India) Pvt Ltd

Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai

Listing : BSE

NEWS

01Jul Fredun Pharmaceuticals moves up as its
Fredun Pharmaceuticals is currently trading at Rs. 837.75, up by 7.30 po..

30Jun Fredun Pharmaceuticals’ arm acquires c
Fredun Pharmaceuticals’ (FPL) wholly owned subsidiary -- Fredun Retail (..

22May Fredun Pharmaceuticals informs about
Pursuant to Regulation 29 read with Regulation 33 of SEBI (Listing Oblig..

10Apr Fredun Pharmaceuticals secures tender
Fredun Pharmaceuticals has been awarded a tender by the Tamil Nadu Medic..

03Apr Fredun Pharmaceutical informs about pr
Fredun Pharmaceutical has informed that it enclosed press release titled..

Financials

Rs. in Millions

	QTR Jun 25	ANNUAL 25
Net Profit	67.6500000000001	208.08
Gross Profit	90.4000000000001	282.71
Operating Profit	169.91	550.97
Net Sales	1198.55	4562.68

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Glenmark Pharma (BSE) 2053.50 (3.16%)	M.Cap ( in Cr)57949.94
Acutaas Chemicals (BSE) 1475.10 (3.49%)	M.Cap ( in Cr)12076.48
Coral Laboratories (BSE) 520.90 (8.30%)	M.Cap ( in Cr)186.10
Amrutanjan Healthcar (BSE) 769.30 (5.17%)	M.Cap ( in Cr)2224.09
Blue Jet Healthcare (BSE) 744.20 (4.99%)	M.Cap ( in Cr)12909.30

Shareholding Pattern

	NON-INSTITUTION	49.48%
	PROMOTERS	48.93%
	FI/BANKS/INSURANCE	1.59%
	MUTUAL FUNDS/UTI	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

FREDUN PHARMACEUTICALS LTD.